What is the dosage of Kisqali?

Kisqali is available in 3 dosages, including mixed Pack, mixed Pack and mixed Pack

What does Kisqali treat?

Kisqali treats Breast Neoplasms

What is Kisqali made of?

Kisqali contains ribociclib which is a Kinase Inhibitor

How is Kisqali administered?

Kisqali is administered as a Pack

What is Kisqali mechanism of action?

Kisqali mechanism of action is Cytochrome P450 3A Inhibitors or Kinase Inhibitors

Dosage & Administration Drug label Samples Prior authorization Financial assistance

Patient education

Kisqali

(ribociclib)

ribociclib 200 MG Oral Tablet [Kisqali]

NO BLACK BOX WARNING

Dosage & administration

KISQALI tablets are taken orally with or without food in combination with an aromatase inhibitor or fulvestrant.

* Recommended starting dose: 600 mg orally (three 200 mg tablets) taken once daily with or without food for 21 consecutive days followed by 7 days off treatment.
* Dose interruption, reduction, and/or discontinuation may be required based on individual safety and tolerability.

drug label

Kisqali prescribing information

Have more Kisqali questions?

Submit MSL Request

Learn More

Need to report a Kisqali issue?

ONLINE FORMReport adverse event

Learn More

samples

Request Kisqali samples

NOT PROVIDED BY BRANDView Online Sample Form

Learn More

prior authorization

Kisqali Prior authorization resources

NOT PROVIDED BY BRANDComplete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

NOT PROVIDED BY BRANDCoverage Authorization Appeals

Learn More

Benefits investigation

PANO Service Request Form - Patient

PANO Service Request Form - HCP

PANO Service Request Form - Kisqali (PDF): HCP

PANO Service Request Form - Kisqali Femara Copack (PDF): HCP

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Kisqali Financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Porgam - Kisqali

Enroll in Patient Savings Program - Kisqali Femara Copack

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

PANO Service Request Form - Patient

PANO Service Request Form - HCP

PANO Service Request Form - Kisqali (PDF): HCP

PANO Service Request Form - Kisqali Femara Copack (PDF): HCP

Bridge Program

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

PANO Service Request Form - Patient

PANO Service Request Form - HCP

PANO Service Request Form - Kisqali (PDF): HCP

PANO Service Request Form - Kisqali Femara Copack (PDF): HCP

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Kisqali Patient education